Skip to main content
. 2020 Feb 26;9(3):628. doi: 10.3390/jcm9030628

Table 2.

Basic anthropometric and disease characteristics of UC and CD group.

Parameter Ulcerative Colitis
(n = 35)
Crohn’s Disease
(n = 45)
p
Age (years) 42.66 ± 15.57 37.56 ± 13.38 0.119 *
Male gender 21 (60.0%) 29 (64.4%) 0.684 **
Body weight (kg) 77.31 ± 13.03 73.26 ± 14.92 0.206 *
Body height (cm) 176.29 ± 8.47 176.51 ± 10.03 0.915 *
BMI (kg/m2) 24.90 ± 3.98 23.38 ± 3.65 0.079 *
BMI categories Underweight (<18.5 kg/m2) 2 (5.7%) 1 (2.2%) 0.093 ***
Normal weight (18.5–24.9 kg/m2) 14 (40.0%) 25 (55.6%)
Overweight (25.0–29.9 kg/m2) 18 (51.4%) 18 (40.0%)
Obesity class I (30.0–34.9 kg/m2) 1 (2.9%) 1 (2.2%)
Waist-hip ratio 0.9 (0.8–1.0) 0.9 (0.8–0.9) 0.284 ****
SES-CD - 10 (5–15) -
CDAI - 57 (32–102) -
HBI - 2 (1–4) -
UCEIS 6 (5–7) - -
MES 2 (2–3) - -
Mayo/DAI 4 (2–7) - -
Disease duration (years) 9 (5–11) 6 (3–13) 0.268 ****
Positive family history on CRC 6 (17.1%) 7 (15.6%) 0.849 **
Positive family history on IBD 7 (20.0%) 9 (20.0%) 1.000 **
Positive family history on CV disease 11 (31.4%) 18 (40.0%) 0.429 **
Alcohol consumption 9 (25.7%) 14 (31.1%) 0.597 **
Active smoking 7 (20.0%) 12 (26.7%) 0.487 **
IBD-related surgical procedures 1 (2.9%) 16 (35.6%) <0.001 ***
Extraintestinal manifestations 6 (18.2%) 27 (62.8%) <0.001 **
Aminosalicylates 30 (85.7%) 27 (60.0%) 0.012 **
DMARD 12 (34.3%) 11 (24.4%) 0.335 **
Monoclonal antibodies 21 (60.0%) 30 (66.7%) 0.538 **

Continuous parametric data are presented as mean ± standard deviation, continuous non-parametric data are presented as median (interquartile range) and categorical data are presented as number (percentage). BMI: body mass index; SES-CD: simple endoscopic score for Crohn’s disease; CDAI: Crohn’s disease activity index; HBI: Harvey-Bradshaw index; UCEIS: ulcerative colitis endoscopic index of severity; MES: Mayo endoscopic score; Mayo/DAI: Mayo score/disease activity index for ulcerative colitis; CRC: colorectal cancer; IBD: inflammatory bowel disease; CV: cardiovascular; DMARD: disease modifying antirheumatic drugs. * Student t-test for independent samples. ** Chi-square test. *** Fisher’s exact test. **** Mann–Whitney U test.